| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.2M | +19.9% |
| Cost of Revenue | $20.4M | -15.3% |
| Gross Profit | $2.8M | +158.2% |
| R&D Expense | $458K | +8.5% |
| SG&A Expense | $16.5M | -32.5% |
| Operating Income | -$33.8M | +22.1% |
| Pre-tax Income | -$34.0M | +21.7% |
| Income Tax | $164K | -44.3% |
| Net Income | -$34.1M | +21.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | -18.7% |
| Current Assets | $17.4M | +34.3% |
| Total Assets | $25.0M | +22.2% |
| Current Liabilities | $11.1M | -1.3% |
| Long-term Debt | $0 | — |
| Total Liabilities | $49.9M | +303.8% |
| Stockholders' Equity | -$22.4M | -344.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.0M | +31.6% |
| Capital Expenditures | $49K | +816.2% |
| Investing Cash Flow | $187K | -3.9% |
| Financing Cash Flow | $23.5M | -12.5% |
| Free Cash Flow | -$24.1M | +31.5% |